Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation
Year: 2023
Type: article
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
Award: G5031486864
OpenAlex ID: W4388698658
